© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
January 13, 2022
The pivotal trial of MINIject, STAR-V, now initiated in 13 sites across the US, has received positive feedback from glaucoma surgeons involved in the trial.
January 11, 2022
Marking Glaucoma Awareness Month this month, Bausch + Lomb and the Glaucoma Research Foundation have released key findings from a survey of glaucoma patients that was designed to gain a greater understanding of the impact that hyperemia can have in the treatment and lives of people living with glaucoma.
December 21, 2021
Mahmoud A. Khaimi, MD, developed a minimally invasive glaucoma surgery known as ab-interno canaloplasty as a treatment option between topical therapies and invasive surgery. The technique continues to prove its value.
December 07, 2021
The company’s IOPerfect combines artificial intelligence in a VR-like headset to allow tele-diagnosis and remote monitoring of glaucoma.
November 09, 2021
Alcon this week announced its plans to acquire glaucoma surgery device maker Ivantis Inc. in a $475 million deal.
October 29, 2021
Investigators in Australia are developing a new rapid screening test for glaucoma that could help advance early detection of the disease.
October 21, 2021
A coalition of vision groups held a briefing on Capitol Hill this week to educate legislators on increasing incidence of myopia and the associated cost burden.
October 14, 2021
To mark World Sight Day, Nanodropper Inc. has developed a pay-it-forward Nanodropper Adaptor program, allowing anyone to donate devices to a pool for distribution to patients in need.
September 08, 2021
TearClear to start clinical trial for TC-002 latanoprost ophthalmic solution 0.005%.
July 13, 2021
New strategies are needed to rethink how we treat glaucoma to do more than just manage eye pressure—to actually restore vision by promoting the survival of retinal ganglion cells and their axons.